Kunal Kamble, sr. technical research analyst at Bonanza, has recommended buying shares of Concord Biotech, Carysil, and Welspun Enterprises today
Concord Biotech shares jumped 5.8 per cent on BSE after USFDA cleared Tofacitinib Tablets ANDA
Concord Biotech received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL.
Stocks to Watch today, June 3: Infosys, Alkem Labs, Paytm among others in focus; here's why
Antique expects the Concord to report revenue, Ebitda and PAT CAGR of 18 per cent, 17 per cent and 19 per cent, respectively, with margins remaining stable at around 42 per cent over FY25-28E